Amy W. Schulman, Director: Alnylam Pharmaceuticals ALNY Sell · Filed 24/06/27

Trade details

Type: Insider sale
Amount: $2,040,000
Shares · price: 8,500 sh · $240.00 a share
Held after: 8,436 sh
Stock: Alnylam Pharmaceuticals ALNY
Person: Amy W. SchulmanDirector
Trade date: 24/06/25
Filed: 24/06/27
Days to filing: 2 days

Sold 50.2% of holdings

Share of holding sold: 50.2%

Alnylam Pharmaceuticals trades, last 26 weeks

What else happened in Alnylam Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/05/26~24/07/25

Amy W. Schulman's recent trades

Amy W. SchulmanDirector
SellElevance Health
Sell
Elevance Health
ELV
$7,475
26 sh
$7,475
Filed 03/23
Traded 03/12
Amy W. Schulman10% Owner
BuyCamp4 Therapeutics
Buy
Camp4 Therapeutics
CAMP
$1.9M
1,221,721 sh
$1.9M
Filed 25/09/11
Traded 25/09/11
Amy W. Schulman10% Owner
BuyCamp4 Therapeutics
Buy
Camp4 Therapeutics
CAMP
$130.8K
85,468 sh
$130.8K
Filed 25/09/11
Traded 25/09/11
Amy W. SchulmanDirector
BuyFractyl Health
Buy
Fractyl Health
GUTS
$10K
8,550 sh
$10K
Filed 25/03/17
Traded 25/03/13
Amy W. Schulman10% Owner
BuyCamp4 Therapeutics
Buy
Camp4 Therapeutics
CAMP
$10M
909,090 sh
$10M
Filed 24/10/22
Traded 24/10/15

Amy W. Schulman, Director — sold $2M of Alnylam Pharmaceuticals ALNY · 50.2% of holdings · 10b5-1 plan | Whalegun